Financial Information
OrBec® Clinical Update - September 15, 2011 - 9 AM Eastern TimeInvestor Center
Soligenix (formerly known as DOR BioPharma), Inc.'s common stock is listed on the Over The Counter Bulletin Board® securities market under the symbol SNGX. Stockholders and interested parties are urged to contact our main office in Princeton, New Jersey at 609-538-8200 or send an e-mail to ir@soligenix.com for further information.
Financial and Corporate Governance Information
- Soligenix Stock Quote (Website link)
- Soligenix Filings with the SEC (Website link)
- Code of Ethics
- Audit Committee Charter (PDF)
- Compensation Committee Charter (PDF)
- Nominating Committee Charter (PDF)
Literature Request
If you would like to receive our Investor Relations Packet, including reprints of scientific publications relating to our products, click here. Thank you for your interest.
